iShares MSCI Netherlands ETF (EWN)
Look-through valuation · Country · Expense ratio 0.50 % · ISIN US4642868149
Price history (since 1996)
Monthly close since 1996. Price shows performance, the valuation verdict is in the look-through above.
Top holdings
| Holding | Weight | vs fair value | Quality |
|---|---|---|---|
| ASML Holding N.V. ASML | 25.8 % | −71.5 % | 81 |
| ING Groep NV INGA | 8.6 % | −1.0 % | 62 |
| Prosus N.V. PRX | 5.2 % | +41.5 % | 57 |
| ASM International NV ASM | 4.6 % | −67.9 % | 74 |
| Nebius Group N.V. NBIS | 4.0 % | −72.4 % | 63 |
| Koninklijke Ahold Delhaize NV AD | 3.3 % | +49.3 % | 66 |
| ABN Amro Group NV ABN | 2.6 % | −6.6 % | 73 |
| AerCap Holdings NV AER | 2.5 % | +104.0 % | 60 |
| Heineken HEIA | 2.4 % | −14.6 % | 64 |
| NN Group NV NN | 2.3 % | −24.3 % | 60 |
| Adyen NV ADYEN | 2.3 % | −18.9 % | 53 |
| BE Semiconductor Industries NV BESI | 2.3 % | −79.1 % | 80 |
| Coca-Cola European Partners PLC CCEP | 2.2 % | −24.3 % | 69 |
| Universal Music Group N.V. UMG | 2.2 % | −19.7 % | 46 |
| Koninklijke Philips NV PHIA | 2.0 % | −39.5 % | 58 |
| Koninklijke KPN NV KPN | 1.9 % | −12.8 % | 57 |
| DSM-Firmenich AG DSFIR | 1.9 % | n/a | n/a |
| Wolters Kluwer N.V. WKL | 1.7 % | +48.8 % | 64 |
| ASR Nederland NV ASRNL | 1.4 % | −46.7 % | 44 |
| Aegon NV AGN | 1.4 % | +6.4 % | 62 |
| Akzo Nobel NV AKZA | 1.2 % | −27.3 % | 52 |
| Heineken Holding NV HEIO | 1.2 % | +4.1 % | 59 |
| The Magnum Ice Cream Company N.V. MICC | 1.2 % | n/a | n/a |
| IMCD NV IMCD | 0.9 % | −15.6 % | 49 |
| Exor N.V. EXO | 0.9 % | −80.0 % | 55 |
Fair value and quality per position come from the same valuation as our stock pages. Showing the 25 largest of 55 disclosed positions. "n/a" means the position is not (yet) in our stock universe and does not enter the average.
How the look-through works
An ETF has no fair value of its own like a single stock. We build it bottom up: every holding has a fair value and a quality score on our pages. Weighted by portfolio share, that gives iShares MSCI Netherlands ETF an average of how cheap or expensive its companies currently sit versus fair value, and how high their average quality is.
As of: Jul 17, 2026
No investment advice, no buy or sell recommendation. The look-through is a computed summary of public fundamentals and is no substitute for your own research.